CORC

在结果中检索

CORC

浏览/检索结果: 共10条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Inhibition of MAPK/ERK pathway promotes oligodendrocytes generation and recovery of demyelinating diseases 期刊论文
GLIA, 2019, 卷号: 67, 期号: 7, 页码: 1320-1332
作者:  Suo, Na;  Guo, Yu-e;  He, Bingqing;  Gu, Haifeng;  Xie, Xin
收藏  |  浏览/下载：26/0  |  提交时间：2020/07/01
SRC and MEK Co-inhibition Synergistically Enhances the Anti-tumor Effect in Both Non-small-cell Lung Cancer (NSCLC) and Erlotinib-Resistant NSCLC 期刊论文
FRONTIERS IN ONCOLOGY, 2019, 卷号: 9
作者:  Yuan, Man;  Xu, Lin-feng;  Zhang, Juan;  Kong, Si-yuan;  Wu, Man
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05
A benzoxazole compound as a novel MEK inhibitor for the treatment of RAS/RAF mutant cancer 期刊论文
2019, 卷号: 145, 期号: 2, 页码: 586-596
作者:  Cheng, Ying;  Wang, Xingkai;  Xia, Xiangying;  Zhang, Wei;  Tian, Hongqi
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
Phosphodiesterase 4 Inhibitor Roflumilast Protects Rat Hippocampal Neurons from Sevoflurane Induced Injury via Modulation of MEK/ERK Signaling Pathway 期刊论文
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 卷号: 45, 期号: 6
作者:  Peng, Sheng;  Yan, Hong-Zhu;  Liu, Pei-Rong;  Shi, Xiao-Wei;  Liu, Chun-Liang
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
Phosphodiesterase 4 Inhibitor Roflumilast Protects Rat Hippocampal Neurons from Sevoflurane Induced Injury via Modulation of MEK/ERK Signaling Pathway 期刊论文
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, 卷号: 45, 页码: 2329-2337
作者:  Peng Sheng[1];  Yan Hong-Zhu[2];  Liu Pei-Rong[3];  Shi Xiao-Wei[4];  Liu Chun-Liang[5]
收藏  |  浏览/下载：7/0  |  提交时间：2019/04/24
The impact of P-glycoprotein and breast cancer resistance protein on the brain pharmacokinetics and pharmacodynamics of a panel of MEK inhibitors 期刊论文
INTERNATIONAL JOURNAL OF CANCER, 2018, 卷号: 142, 期号: 2, 页码: 381-391
作者:  de Gooijer, Mark C.;  Zhang, Ping;  Weijer, Ruud;  Buil, Levi C. M.;  Beijnen, Jos H.
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/11
Incidence and relative risk of cutaneous squamous cell carcinoma with single-agent BRAF inhibitor and dual BRAF/MEK inhibitors in cancer patients: a meta-analysis 期刊论文
ONCOTARGET, 2017, 卷号: 8, 期号: 47
作者:  Peng, Ling;  Wang, Yina;  Hong, Yun;  Ye, Xianghua;  Shi, Peng
收藏  |  浏览/下载：13/0  |  提交时间：2019/12/05
MEK inhibitor can reverse the resistance to bevacizumab in A549 cells harboring Kirsten rat sarcoma oncogene homolog mutation 期刊论文
2016, 卷号: 7, 期号: 3, 页码: 279-287
作者:  Wang, Yuan;  Yan, Ping;  Liu, Zhentao;  Yang, Xiaodan;  Wang, Yaping
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04
Up-regulation of urinary-type plasminogen activator correlates with high-risk papillary thyroid carcinoma with BRAFV600E mutation and its possible molecular mechanism 期刊论文
Pathology Research and Practice, 2014, 卷号: 210, 期号: 11, 页码: 733-738
作者:  Wakasa,T.;  Li,Y.;  Bai,Y.;  Liu,Z.;  Ozaki,T.
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/17
The crossregulation between ERK and PI3K signaling pathways determines the tumoricidal efficacy of MEK inhibitor 期刊论文
JOURNAL OF MOLECULAR CELL BIOLOGY, 2012, 卷号: 4
-
收藏  |  浏览/下载：13/0  |  提交时间：2020/10/26

©版权所有 ©2017 CSpace - Powered by CSpace